How many insider declarations has Frazier Life Sciences XI, L.P. filed?

Frazier Life Sciences XI, L.P. has filed 5 public insider declarations with SEC (Form 4).

What is Frazier Life Sciences XI, L.P.'s role?

Frazier Life Sciences XI, L.P.'s reported role is not specified by the regulator across the filings.

Which companies does Frazier Life Sciences XI, L.P. report trades for?

Frazier Life Sciences XI, L.P. reports trades for Attovia Therapeutics, Inc..

What is Frazier Life Sciences XI, L.P.'s declared buy vs sell volume?

Across the available history, declared buys total 8.6M€ and disposals 0.

← Executives ★ Sign in to follow

FL

Frazier Life Sciences XI, L.P.

·SEC (Form 4)

Attovia Therapeutics, Inc.

0

Total declarations

0

Company

€9m

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Explore the complete record of transactions filed by Frazier Life Sciences XI, L.P.. Director active across 1 company, notably Attovia Therapeutics, Inc.. Aggregated, 5 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €8.6m. Activity tracked since 6 August 2026. The latest transaction was disclosed on 6 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.

Companies and markets linked to Frazier Life Sciences XI, L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Attovia Therapeutics, Inc. (US)

Declarations5 total

●

Frazier Life Sciences XI, L.P.

10% OwnerExecutives6 Aug 2026Attovia Therapeutics, Inc.

0SEC ↗

1,749,192 sharesCommon StockSEC:0001231919-26-000838:0

●

Frazier Life Sciences XI, L.P.

10% OwnerExecutives6 Aug 2026Attovia Therapeutics, Inc.

0SEC ↗

1,590,175 sharesCommon StockSEC:0001231919-26-000838:1

●

Frazier Life Sciences XI, L.P.

10% OwnerExecutives6 Aug 2026Attovia Therapeutics, Inc.

0SEC ↗

1,189,940 sharesCommon StockSEC:0001231919-26-000838:2

●

Frazier Life Sciences XI, L.P.

10% OwnerExecutives6 Aug 2026Attovia Therapeutics, Inc.

0SEC ↗

961,322 sharesCommon StockSEC:0001231919-26-000838:3

▲

Frazier Life Sciences XI, L.P.

10% OwnerExecutives6 Aug 2026Attovia Therapeutics, Inc.

$10M0SEC ↗

588,235 shares@ US$17.00Common StockSEC:0001231919-26-000838:4

Canonical exit: 4 Nov 2026 (T+90)

5 of 5 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

FL

Frazier Life Sciences XI, L.P.

·SEC (Form 4)

Attovia Therapeutics, Inc.

0

Total declarations

0

Company

€9m

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Explore the complete record of transactions filed by Frazier Life Sciences XI, L.P.. Director active across 1 company, notably Attovia Therapeutics, Inc.. Aggregated, 5 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €8.6m. Activity tracked since 6 August 2026. The latest transaction was disclosed on 6 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.